Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 6 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 10 analysts offering 12 month price targets for Avadel Pharmaceuticals PLC (ADR) have a median target of 22.50, with a high estimate of 30.00 and a low estimate of 20.00. The median estimate represents a 92.97% increase from the last price of 11.66.
High | 157.3% | 30.00 |
Med | 93.0% | 22.50 |
Low | 71.5% | 20.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 03, 2025.
Average growth rate | +39.43% |
Average growth rate | -30.41% |
More ▼
Revenue history & estimates in USD
Average growth rate | +72.57% |
Average growth rate | -54.09% |
More ▼